Trial Profile
Zoledronic acid versus bisphosphonates following teriparatide therapy in patients with osteoporosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jun 2011
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary) ; Alendronic acid; Risedronic acid; Teriparatide
- Indications Male osteoporosis; Postmenopausal osteoporosis
- Focus Therapeutic Use
- 08 Jun 2011 New trial record
- 28 May 2011 Results presented at the 12th Annual Congress of the European League Against Rheumatism.